Join co-hosts PRAXIS and ACTA on twitter for a short series of tweetchats focussed on COVID-19 support and information exchange for clinical trials.
Use the hashtag #WhyWeDoResearch on Tuesday 28 April and Thursday 30 April from 8pm AEST to follow and participate in the tweetchat.
Latest Resources
-
-
Case study: Networking and information were key in setting up NECST
-
Case study: How the Drug and Alcohol Clinical Research and Improvement Network (DACRIN) is enhancing consumer involvement in research
-
Recommendations to improve cultural and linguistic diversity in clinical trials
-
Development of the Consumer Involvement and Engagement Toolkit
-
A snapshot of consumer engagement in clinical trials in Australia
-
HeSANDA initiative stakeholder consultation project – final report
-
HeSANDA initiative stakeholder consultation project – Executive Summary of key findings
-
HeSANDA Stakeholder Consultation Project
-
Consumer involvement in clinical trials: ethics committee members and research governance personnel training webinar – an overview
-
Consumers in Clinical Trials: Jenny Lam
-
Consumers in Clinical Trials: Zy Phillips
-
Consumers in Clinical Trials: Mitch Messer
-
ACTA Clinical Trial Diversity: CALD project
-
Beyond COVID-19: A solution-focussed forum
-
NCRIS Offerings Pack
-
Consumer Involvement and Engagement Toolkit
-
What is randomisation?
-
What are clinical trials?
-
Consumer Involvement Consultation Report
-
The Health Consumer’s Perspective: Now and in the next five years
-
Report on the Activities and Achievements of Clinical Trials Networks in Australia 2004-2014
Latest Events
-
Applying a simplified consent approach for low-risk clinical trials webinar
-
Clinical Trials 2021: National Tribute and Award Ceremony
-
Consumer & Community Involvement in Clinical Trials ACTA Training Workshop
-
Trial Participants & COVID-19: considerations and strategies for running trials during the pandemic
-
Clinical Trials for COVID-19 Treatment and Prevention
-
Pharmacovigilance and Regulatory Affairs & COVID-19: considerations and strategies for running trials during the pandemic
-
Private Sector & COVID-19: considerations and strategies for running trials during the pandemic
-
Academics & COVID-19: considerations and strategies for running trials during the pandemic
-
Role of Clinical Trial Sponsors & COVID-19: considerations and strategies for running trials during the pandemic
-
Best Practice Guidance for Clinical Trial Sites in COVID-19: Consolidating the information
-
Ethics Committees and Governance & COVID-19: considerations and strategies for running trials during the pandemic
-
Jurisdictions: Federal/States & COVID-19: considerations and strategies for running trials during the pandemic
-
Peak Bodies and TGA & COVID-19: considerations and strategies for running trials during the pandemic